A unifying hypothesis of Alzheimer's disease. III. Risk factors
- 1 January 2000
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
Abstract
Normal ageing and Alzheimer's disease (AD) have many features in common and, in many respects, both conditions only differ by quantitative criteria. A variety of genetic, medical and environmental factors modulate the ageing‐related processes leading the brain into the devastation of AD. In accordance with the concept that AD is a metabolic disease, these risk factors deteriorate the homeostasis of the Ca2+–energy–redox triangle and disrupt the cerebral reserve capacity under metabolic stress. The major genetic risk factors (APP and presenilin mutations, Down's syndrome, apolipoprotein E4) are associated with a compromise of the homeostatic triangle. The pathophysiological processes leading to this vulnerability remain elusive at present, while mitochondrial mutations can be plausibly integrated into the metabolic scenario. The metabolic leitmotif is particularly evident with medical risk factors which are associated with an impaired cerebral perfusion, such as cerebrovascular diseases including stroke, cardiovascular diseases, hypo‐ and hypertension. Traumatic brain injury represents another example due to the persistent metabolic stress following the acute event. Thyroid diseases have detrimental sequela for cerebral metabolism as well. Furthermore, major depression and presumably chronic stress endanger susceptible brain areas mediated by a host of hormonal imbalances, particularly the HPA‐axis dysregulation. Sociocultural and lifestyle factors like education, physical activity, diet and smoking may also modulate the individual risk affecting both reserve capacity and vulnerability. The pathophysiological relevance of trace metals, including aluminum and iron, is highly controversial; at any rate, they may adversely affect cellular defences, antioxidant competence in particular. The relative contribution of these factors, however, is as individual as the pattern of the factors. In familial AD, the genetic factors clearly drive the sequence of events. A strong interaction of fat metabolism and apoE polymorphism is suggested by intercultural epidemiological findings. In cultures, less plagued by the ‘blessings’ of the ‘cafeteria diet–sedentary’ Western lifestyle, apoE4 appears to be not a risk factor for AD. This intriguing evidence suggests that, analogous to cardiovascular diseases, apoE4 requires a hyperlipidaemic lifestyle to manifest as AD risk factor. Overall, the etiology of AD is a key paradigm for a gene‐environment interaction. Copyright © 2000 John Wiley & Sons, Ltd.Keywords
This publication has 998 references indexed in Scilit:
- HLA A2 allele is associated with age at onset of Alzheimer's diseaseAnnals of Neurology, 1999
- Initial results of a genome survey for novel alzheimer's disease risk genes: Association with a locus on the X chromosomeAmerican Journal of Medical Genetics, 1998
- Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypesAnnals of Neurology, 1997
- Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptideJournal of Cellular Physiology, 1997
- Alzheimer's disease-associated presenilin 1 in neuronal cells: Evidence for localization to the endoplasmic reticulum-Golgi intermediate compartmentJournal of Neuroscience Research, 1997
- Increased apolipoprotein E ϵ4 in epilepsy with senile plaquesAnnals of Neurology, 1997
- Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)Annals of Neurology, 1996
- Alzheimer's disease and apolipoprotein e‐4 allele in an amish populationAnnals of Neurology, 1996
- Time‐Dependent Rundown of GABA Response in Mammalian CNS Neuron During Experimental AnoxiaObesity Research, 1995
- Mechanisms involved in activity‐dependent synapse formation in mammalian central nervous system cell culturesJournal of Neurobiology, 1990